Channing Capital Management’s Zimmer Biomet ZBH Stock Holding History

Channing Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-41,140	Closed	-$5.99M	–	168
2023 Q2	$5.99M	Sell	41,140 -13,544	-25%	-$1.84M	0.18%	96
2023 Q1	$7.07M	Sell	54,684 -24,267	-31%	-$3.05M	0.23%	85
2022 Q4	$10.1M	Buy	78,951 +6,306	+9%	+$732K	0.32%	76
2022 Q3	$7.59M	Sell	72,645 -266	-0.4%	-$29.2K	0.26%	86
2022 Q2	$7.66M	Sell	72,911 -875	-1%	-$104K	0.25%	85
2022 Q1	$9.44M	Sell	73,786 -9,814	-12%	-$1.18M	0.28%	79
2021 Q4	$10.3M	Buy	83,600 +16,178	+24%	+$2.12M	0.29%	81
2021 Q3	$9.58M	Buy	+67,422	New	+$9.92M	0.3%	90
2018 Q4	–	Sell	-62,913	Closed	-$8.03M	–	113
2018 Q3	$8.03M	Sell	62,913 -27,899	-31%	-$3.32M	0.29%	76
2018 Q2	$9.82M	Sell	90,812 -28,270	-24%	-$3.08M	0.35%	62
2018 Q1	$12.6M	Sell	119,082 -27,879	-19%	-$3.24M	0.44%	57
2017 Q4	$17.2M	Buy	146,961 +62,349	+74%	+$7.05M	0.58%	46
2017 Q3	$9.62M	Buy	+84,612	New	+$9.77M	0.36%	66

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Channing Capital Management's ZBH Position: Q3 2023 in Review

Channing Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 41,140 shares — an estimated $5.99M sold.

Channing Capital Management first reported a position in ZBH in Q3 2017 and held it in 13 quarters. The position peaked at $17.2M in Q4 2017. 1,017 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

Channing Capital Management reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
Channing Capital Management sold 41,140 Zimmer Biomet shares in Q3 2023, an estimated $5.99M.
Channing Capital Management first reported a position in Zimmer Biomet in Q3 2017 and held it in 13 quarters.
Channing Capital Management's Zimmer Biomet position peaked at $17.2M in Q4 2017.
1,017 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Channing Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.